Dr Chris J Kapelios (Laiko General Hospital, Athens, GR) discusses sacubitril / valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-term Registry: bridging between the PARADIGM HF trial, ESC Guidelines and the real world.

Questions:

Why did you conduct this analysis?

How did you collect and analyse the data?

What were your findings?

How should this study influence practice and research with Sacubitril/valsartan?

Interviewer: Liam O'Neill

Videographer: Mike Knight

Filmed on site at HFA 2019.